Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB811 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human BMPR-II Monoclonal Antibody (Clone 73805)
- Antibody type
- Monoclonal
- Antigen
- Mouse myeloma cell line NS0-derived recombinant human BMPR-II, Ala26-Ile151
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
Q13873
- Isotype
- IgG
- Vial size
- 500 µg
Submitted references TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
Casein kinase II contributes to the synergistic effects of BMP7 and BDNF on Smad 1/5/8 phosphorylation in septal neurons under hypoglycemic stress.
A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7.
Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Hurst LA, Dunmore BJ, Long L, Crosby A, Al-Lamki R, Deighton J, Southwood M, Yang X, Nikolic MZ, Herrera B, Inman GJ, Bradley JR, Rana AA, Upton PD, Morrell NW
Nature communications 2017 Jan 13;8:14079
Nature communications 2017 Jan 13;8:14079
Casein kinase II contributes to the synergistic effects of BMP7 and BDNF on Smad 1/5/8 phosphorylation in septal neurons under hypoglycemic stress.
Chaverneff F, Barrett J
Journal of neurochemistry 2009 May;109(3):733-43
Journal of neurochemistry 2009 May;109(3):733-43
A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7.
Sengle G, Ono RN, Lyons KM, Bächinger HP, Sakai LY
Journal of molecular biology 2008 Sep 12;381(4):1025-39
Journal of molecular biology 2008 Sep 12;381(4):1025-39
Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET
Cancer research 2005 Sep 15;65(18):8274-85
Cancer research 2005 Sep 15;65(18):8274-85
No comments: Submit comment
No validations: Submit validation data